AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF KONVOMEP™ (omeprazole and sodium bicarbonate for oral suspension)

/PRNewswire/ -- Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs...

Related Keywords

New York ,United States ,Richard Blackburn ,John University College Of Pharmacy Health Sciences ,Prnewswire Azurity Pharmaceuticals ,Drug Administration ,Clinical Health Professions ,Azurity Pharmaceuticals Inc ,Azurity Pharmaceuticals ,Olga Hilas ,University College ,Health Sciences ,Nc ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Fda Approval ,